EULAR recommendations for the management of antiphospholipid syndrome in adults

Tektonidou, Maria G, Andreoli, Laura, Limper, Marteen, Amoura, Zahir, Cervera, Ricard, Costedoat-Chalumeau, Nathalie, Cuadrado, Maria Jose, Dörner, Thomas +16 more·2019·Annals of the Rheumatic Diseases
DOI 10.1136/annrheumdis-2019-215213

Cited by (1,254)

Items 101–200 of 1,254

  1. Platelets and Thrombotic Antiphospholipid Syndrome
    Ibrahim Tohidi‐Esfahani, Prabal Mittal, David Alan Isenberg, Hannah Cohen, Maria Efthymiou · 2024 · Journal of Clinical Medicine
  2. Recommendations for physical activity and exercise in persons living with Systemic Lupus Erythematosus (SLE): consensus by an international task force
    Julien Blaess, Sophie Geneton, Thibaut Goepfert, Simone Appenzeller, Gabriel Bordier, Thomas Davergne, Yurilís Fuentes-Silva, Håvard Pedersen Haglo, Karen Hambly, Dominique Kinnett-Hopkins et al. · 2024 · RMD Open
  3. Thrombophilia Testing After Ischemic Stroke
    Setareh Salehi Omran, Adam Hartman, Neil A. Zakai, Babak Benjamin Navi · 2021 · Stroke
  4. Antiphospholipid Syndrome Nephropathy and Other Thrombotic Microangiopathies Among Patients With Systemic Lupus Erythematosus
    Elizabeth Kotzen, Sanjeet Roy, Koyal Jain · 2019 · Advances in Chronic Kidney Disease
  5. Antiphospholipid syndrome: a clinical perspective
    Yu Zuo, Hui Shi, Chun Li, Jason S. Knight · 2020 · Chinese Medical Journal
  6. Low Preconception Complement Levels Are Associated with Adverse Pregnancy Outcomes in a Multicenter Study of 260 Pregnancies in 197 Women with Antiphospholipid Syndrome or Carriers of Antiphospholipid Antibodies
    Cecilia Nalli, Daniele Lini, Laura Andréoli, Francesca Crisafulli, Micaela Fredi, Maria Grazia Lazzaroni, Viktoria Bitsadze, Antonia Calligaro, Valentina Canti, Roberto Felice Caporali et al. · 2021 · Biomedicines
  7. ‘Non-criteria antiphospholipid antibodies’: bridging the gap between seropositive and seronegative antiphospholipid syndrome
    Simona Truglia, Silvia Mancuso, Antonella Capozzi et al. · 2021 · Lara D. Veeken
  8. Management of Non-criteria Manifestations in Antiphospholipid Syndrome
    Eleni Xourgia, Maria G. Tektonidou · 2020 · Current Rheumatology Reports
  9. Update on pregnancy complications in systemic lupus erythematosus
    Wendy Marder · 2019 · Current Opinion in Rheumatology
  10. How I treat anticoagulant-refractory thrombotic antiphospholipid syndrome
    Hannah Cohen, David Alan Isenberg · 2020 · Blood
  11. Immune Thrombocytopenia in Antiphospholipid Syndrome: Is It Primary or Secondary?
    Riccardo Tomasello, Giulio Giordano, Francesco Romano · 2021 · Biomedicines
  12. Immunology of pregnancy and reproductive health in autoimmune rheumatic diseases. Update from the 11th International Conference on Reproduction, Pregnancy and Rheumatic Diseases
    Laura Andréoli, Cecilia Beatrice Chighizola, Luca Iaccarino, Angela Botta, Maria Gerosa, Véronique Laure Ramoni, Chiara Tani, Bonnie Lee Bermas, Antonio Luca Brucato, Jill P. Buyon et al. · 2022 · Autoimmunity Reviews
  13. Whole blood transcriptome identifies interferon-regulated genes as key drivers in thrombotic primary antiphospholipid syndrome
    Kleio‐Maria Verrou, Petros Paul Sfikakis, Maria G. Tektonidou · 2022 · Journal of Autoimmunity
  14. How to Interpret Antiphospholipid Laboratory Tests
    Katrien M.J. Devreese · 2020 · Current Rheumatology Reports
  15. Kidney disease in antiphospholipid antibody syndrome: Risk factors, pathophysiology and management
    Marc Scheen, Amir Adedjouma, Emmanuel Estève, David Buob, Noémie Abisror, Virginie Planche, O. Fain, J.J. Boffa, Sophie de Seigneux, Arsène MEKINIAN et al. · 2022 · Autoimmunity Reviews
  16. Antiphospholipid syndrome and antiphospholipid antibody profile in patients with retinal vein occlusion
    José L. Hernández, Iria Sanlés González, Rocío Pérez‐Montes, Víctor Manuel Martínez-Taboada, José Manuel Olmos, Zaida Salmón, Isabel Sierra, Estefanía Escalante, José Javier Napal · 2020 · Thrombosis Research
  17. Treatment of antiphospholipid syndrome
    Massimo Radin, Irene Cecchi, Elena Rubini, Silvia Grazietta Foddai, Alice Barinotti, Elisa Menegatti, Dario Roccatello, Savino Sciascia · 2020 · Clinical Immunology
  18. Role of Lipid Rafts on LRP8 Signaling Triggered by Anti-β2-GPI Antibodies in Endothelial Cells
    Gloria Riitano, Antonella Capozzi, Serena Recalchi · 2023 · Biomedicines
  19. Single-cell transcriptome analyses reveal disturbed decidual homoeostasis in obstetric antiphospholipid syndrome
    Chenyang Lu, Rui Gao, Pingying Qing, Xun Zeng, Xin Liao, Meng Cheng, Lang Qin, Yi Liu · 2024 · Annals of the Rheumatic Diseases
  20. 2024 ACC Expert Consensus Decision Pathway on Practical Approaches for Arrhythmia Monitoring After Stroke
    Michael T. Spooner, Steven Russell Messe, Seemant Chaturvedi, Monika M. Do, Ty J. Gluckman, Janet K. Han, Andrea M. Russo, Sherry J. Saxonhouse, Newton B. Wiggins · 2024 · Journal of the American College of Cardiology
  21. Comparable or higher prevalence of comorbidities in antiphospholipid syndrome vs rheumatoid arthritis: a multicenter, case-control study
    Stylianos Panopoulos, Κonstantinos Thomas, Georgios A. Georgiopoulos, Dimitrios T. Boumpas, Christina G. Katsiari, George K Bertsias, Alexandros A. Drosos, Kyriaki A. Boki, Theodoros Dimitroulas, Alexandros Garyfallos et al. · 2020 · Rheumatology
  22. Libman-Sacks endocarditis and associated cerebrovascular disease: The role of medical therapy
    Carlos A. Roldan, Wilmer L. Sibbitt, Ernest R. Greene, Clifford Qualls, Rex Eugene Jung · 2021 · PLoS ONE
  23. Antiprothrombin antibodies induce platelet activation: A possible explanation for anti‐FXa therapy failure in patients with antiphospholipid syndrome?
    Walid Chayouâ, Phillip L.R. Nicolson, Joost C.M. Meijers · 2021 · Journal of Thrombosis and Haemostasis
  24. Case Report: Resetting the Humoral Immune Response by Targeting Plasma Cells With Daratumumab in Anti-Phospholipid Syndrome
    Daniel Enrique Pleguezuelo, Raquel Díaz‐Simón, Óscar Cabrera-Marante, Antonio Lalueza, Estela Paz‐Artal, Carlos Lumbreras, Antonio Serrano Hernández · 2021 · Frontiers in Immunology
  25. Clinical characteristics and prognosis of patients with antiphospholipid antibodies based on cluster analysis: an 8-year cohort study
    Qi, Wanting, Zhao, Jiuliang, Huang, Can, Jiang, Nan, Li, Jing, Wu, Chanyuan, Zhang, Shangzhu, Hu, Chaojun, Xu, Dong, Wang, Qian et al. · 2022 · Arthritis Research & Therapy
  26. The Impacts of Inflammatory and Autoimmune Conditions on the Endometrium and Reproductive Outcomes
    Isabel Cuadrado-Torroglosa, Juan Antonio García-Velasco, Diana Alecsandru · 2024 · Journal of Clinical Medicine
  27. Autoimmune diseases and pregnancy
    Anǵela Tincani, Cecilia Nalli, Jamilya Kh. Khizroeva, Victoria O. Bitsadze, Andrea Lojacono, Laura Andréoli, Yehuda Shoenfeld, Alexander Davidovich Makatsariya · 2019 · Best Practice & Research Clinical Endocrinology & Metabolism
  28. Autoantibodies in connective tissue disease
    Ben Mulhearn, Sarah Tansley, Neil John McHugh · 2019 · Best Practice & Research Clinical Rheumatology
  29. The Weight of IgA Anti-β2glycoprotein I in the Antiphospholipid Syndrome Pathogenesis: Closing the Gap of Seronegative Antiphospholipid Syndrome
    Óscar Cabrera-Marante, Edgard Rodríguez de Frías, Manuel Serrano, Fernando Lozano, Laura Naranjo, Francisco Javier Gil‐Etayo, Estela Paz‐Artal, Daniel Enrique Pleguezuelo, Antonio Serrano · 2020 · International Journal of Molecular Sciences
  30. Effect of Hydroxychloroquine on Lupus Activity, Preeclampsia and Intrauterine Growth Restriction in Pregnant Women with Systemic Lupus Erythematosus and/or Antiphospholipid Syndrome: A Systematic Review and Meta-Analysis
    Zhengyan Hu, Rui Gao, Wanrong Huang, Huiqing Wang, Lang Qin · 2023 · Journal of Clinical Medicine
  31. Metabolic syndrome in antiphospholipid syndrome versus rheumatoid arthritis and diabetes mellitus: Association with arterial thrombosis, cardiovascular risk biomarkers, physical activity, and coronary atherosclerotic plaques
    Eleana Bolla, Nikolaοs Tentolouris, Petros Paul Sfikakis, Maria G. Tektonidou · 2023 · Frontiers in Immunology
  32. Positive antiphospholipid antibodies: observation or treatment?
    Bogna Grygiel‐Górniak, Łukasz Mazurkiewicz · 2023 · Journal of Thrombosis and Thrombolysis
  33. Diagnostic Work-Up in Patients with Nonbacterial Thrombotic Endocarditis
    Antonio Tonutti, Iside Stella Scarfò, Giovanni La Canna, Carlo Francesco Selmi, Maria De Santis · 2023 · Journal of Clinical Medicine
  34. How I diagnose and treat antiphospholipid syndrome in pregnancy
    David Ware Branch, Ming Yeong Lim · 2023 · Blood
  35. 2023 ACR/EULAR classification criteria in existing research cohorts: an international study
    Foddai, Silvia G, Radin, Massimo, Cecchi, Irene, Rubini, Elena, Barinotti, Alice, Alba, Paula, Gimen Alonso, Carla, Rossi, Daniela, Roccatello, Dario, Sciascia, Savino · 2024 · Rheumatology
  36. Does seronegative obstetric APS exist? “pro” and “cons”
    Fabrizio Conti, Laura Andréoli, Francesca Crisafulli · 2019 · Autoimmunity Reviews
  37. Morbidity and mortality in antiphospholipid syndrome based on cluster analysis: a 10-year longitudinal cohort study
    Yusuke Ogata, Yuichiro Fujieda, Masanari Sugawara, Taiki Sato, Naoki Ohnishi, Michihito Kono, Masaru Kato, Kenji Oku, Olga Amengual, Tatsuya Atsumi · 2020 · Rheumatology
  38. Management of Antiphospholipid Syndrome
    Amine Ghembaza, David Saadoun · 2020 · Biomedicines
  39. Antiphospholipid syndrome: Diagnosis and management in the obstetric patient
    Erol Arslan, David Ware Branch · 2019 · Best Practice & Research Clinical Obstetrics & Gynaecology
  40. Hematological manifestations of antiphospholipid syndrome: Going beyond thrombosis
    Georges El Hasbani, Antoine N. Saliba, Imad W. Uthman · 2022 · Blood Reviews
  41. Physical Activity, Alzheimer Plasma Biomarkers, and Cognition
    Seung Ae Kim, Daeun Shin, Hongki Ham, Yeshin Kim, Yuna Gu, Hee Jin Kim, Duk Lyul Na, Henrik Zetterberg, Kaj Blennow, Sang Won Seo et al. · 2025 · JAMA Network Open
  42. Decoding lysophosphatidic acid signaling in physiology and disease: mapping the multimodal and multinodal signaling networks
    Revathy Nadhan, Karthik Nath, Sneha Basu, Ciro Isidoro, Yong Sang Song, Danny N. Dhanasekaran · 2025 · Signal Transduction and Targeted Therapy
  43. Pregnancy and undifferentiated connective tissue disease: outcome and risk of flare in 100 pregnancies
    Dina Zucchi, Chiara Tani, Francesca Monacci et al. · 2019 · Lara D. Veeken
  44. Effect of statins on the prevention of recurrent thrombosis in thrombotic antiphospholipid syndrome
    Oh Chan Kwon, Yong‐Beom Park, Min‐Chan Park · 2021 · Lara D. Veeken
  45. Updates in Cerebral Venous Thrombosis
    Arshia Alimohammadi, Diana J. Kim, Thalia Shoshana Field · 2022 · Current Cardiology Reports
  46. Comparing the efficacy and safety of direct oral anticoagulants versus Vitamin K antagonists in patients with antiphospholipid syndrome: a systematic review and meta-analysis
    Xiaoling Wu, Shaobo Cao, Bo Yu · 2022 · Blood Coagulation & Fibrinolysis
  47. Dilemmas in the diagnosis and management of antiphospholipid syndrome
    James E. Manning, Deepa J. Arachchillage · 2024 · Journal of Thrombosis and Haemostasis
  48. Certolizumab pegol to prevent adverse pregnancy outcomes in patients with antiphospholipid syndrome and lupus anticoagulant (IMPACT): results of a prospective, single-arm, open-label, phase 2 trial
    David Ware Branch, Mimi Kim, Marta M. Guerra, Joseph Worden, Carl A. Laskin, Maria Teresa DeSancho, Inna V. Landres, Jason S. Knight, Haley S Slosberg, Margaret Minett et al. · 2025 · Annals of the Rheumatic Diseases
  49. Systemic lupus erythematosus: new horizons for diagnosis and therapy
    Sergey K. Solovyev, Elena Aleksandrovna Aseeva, Т. В. Попкова, Aleksander M. Lila, Mazurov Vi, Eugeny L. Nasonov · 2020 · Rheumatology Science and Practice
  50. Atherosclerosis progression in antiphospholipid syndrome is comparable to diabetes mellitus: a 3 year prospective study
    Gerasimos Evangelatos, Evrydiki Kravvariti, George D. Konstantonis · 2021 · Lara D. Veeken
  51. Activation of Platelet mTORC2/Akt Pathway by Anti-β2GP1 Antibody Promotes Thrombosis in Antiphospholipid Syndrome
    Zihan Tang, Hui Shi, Changming Chen et al. · 2023 · Arteriosclerosis Thrombosis and Vascular Biology
  52. Antiphospholipid antibodies and pregnancy outcome of assisted reproductive treatment: A systematic review and meta‐analysis
    Rui Gao, Rujun Zeng, Pingying Qing, Meng Cheng, Kemin Cheng, Sirui Zhang, Hanxiao Chen, Xiaolei Jin, Lang Qin, Tao Li · 2021 · American Journal of Reproductive Immunology
  53. Reproductive Issues and Pregnancy Implications in Systemic Sclerosis
    Maria Grazia Lazzaroni, Francesca Crisafulli, Liala Moschetti, Paolo Semeraro, Ana Rita Cunha, Agna Neto, Andrea Lojacono, Francesca Ramazzotto, Cristina Zanardini, Sonia Zatti et al. · 2022 · Clinical Reviews in Allergy & Immunology
  54. An update on inflammation in antiphospholipid syndrome
    Amala Ambati, Yu Zuo, Jason S. Knight · 2022 · Current Opinion in Rheumatology
  55. Anti‐phospholipid antibodies and reproductive failures
    Asmaa Beltagy, Laura Trespìdi, Maria Gerosa, Manuela Wally Ossola, Pier Luigi Meroni, Cecilia Beatrice Chighizola · 2020 · American Journal of Reproductive Immunology
  56. Treatment of neuropsychiatric systemic lupus erythematosus: clinical challenges and future perspectives
    Dionysis Nikolopoulos, Antonis Fanouriakis, George K Bertsias · 2021 · Expert Review of Clinical Immunology
  57. Patterns of Recurrent Thrombosis in Primary Antiphospholipid Syndrome—Multicenter, Real-Life Long-Term Follow-Up
    Stanley Niznik, Micha J. Rapoport, Orly Hamburger Avnery, Aharon Lubetsky, Soad Haj Yahia, Martin H. Ellis, Nancy Agmon‐Levin · 2022 · Frontiers in Immunology
  58. Protection by hydroxychloroquine prevents placental injury in obstetric antiphospholipid syndrome
    Jing Liu, Liting Zhang, Yijia Tian · 2022 · Journal of Cellular and Molecular Medicine
  59. Silent Myocardial Perfusion Abnormalities Detected by Stress Cardiovascular Magnetic Resonance in Antiphospholipid Syndrome: A Case-Control Study
    Sophie I. Mavrogeni, George Markousis‐Mavrogenis, Olga Karapanagiotou et al. · 2019 · Journal of Clinical Medicine
  60. Clinical Management of Thrombotic Antiphospholipid Syndrome
    Nor Rafeah Tumian, Beverley Jane Hunt · 2022 · Journal of Clinical Medicine
  61. Growth differentiation factor 15 (GDF-15) as potential cardiovascular risk biomarker in antiphospholipid syndrome
    Maria G. Tektonidou, Ioannis Papassotiriou, Petros Paul Sfikakis · 2021 · Lara D. Veeken
  62. Anti-phosphatidyl-serine/prothrombin antibodies (aPS/PT) in isolated lupus anticoagulant (LA): is their presence linked to dual test positivity?
    Marta Tonello, Elisa Bison, Maria Grazia Cattini, Elena Pontara, Luca Iaccarino, Gentian Denas, Chun‐Yan Cheng, Vittorio Pengo · 2021 · Clinical Chemistry and Laboratory Medicine (CCLM)
  63. Direct oral anticoagulants versus warfarin in patients with single or double antibody-positive antiphospholipid syndrome
    Briana Williams, Joseph J. Saseen, Toby C. Trujillo, Surabhi Palkimas · 2021 · Journal of Thrombosis and Thrombolysis
  64. The immune thrombocytopenia paradox: Should we be concerned about thrombosis in ITP?
    Artur Saldanha, Marina Pereira Colella, Paula Ribeiro Villaça · 2024 · Thrombosis Research
  65. Challenges and Opportunities of Direct Oral Anticoagulant (DOAC) Therapy in Complex Clinical Scenarios: A Comprehensive Review and Practical Guide
    Giuseppe Miceli, Anna Maria Ciaccio, Antonino Tuttolomondo · 2025 · Journal of Clinical Medicine
  66. Cardiovascular risk management in antiphospholipid syndrome: trends over time and comparison with rheumatoid arthritis and diabetes mellitus
    Eleana Bolla, Nikolas Tentolouris, Petros Paul Sfikakis, Maria G. Tektonidou · 2021 · Lupus Science & Medicine
  67. Direct oral anticoagulants versus warfarin in patients with antiphospholipid syndrome: A meta-analysis of randomized controlled trials
    Young Ho Lee, Gwan Gyu Song · 2022 · Lupus
  68. Antiphospholipid antibody positivity in early systemic lupus erythematosus is associated with subsequent vascular events
    Nicola Farina, Ruya Abdulsalam, Thomas C. R. McDonnell · 2022 · Lara D. Veeken
  69. Characterisation of a high-risk profile for maternal thrombotic and severe haemorrhagic complications in pregnant women with antiphospholipid syndrome in France (GR2): a multicentre, prospective, observational study
    Anne Murarasu, G. Guettrot-Imbert, Véronique Le Guern, Cécile Yelnik, Viviane Queyrel, Nicolas SCHLEINITZ, Nicole Ferreira-Maldent, Élisabeth Diot, G. Urbanski, E. Pannier et al. · 2022 · The Lancet Rheumatology
  70. The many facets of immune-mediated thrombocytopenia: Principles of immunobiology and immunotherapy
    T. Moulinet, Anthony Moussu, Ludovic Pierson, Simona Pagliuca · 2023 · Blood Reviews
  71. Direct oral anticoagulants versus vitamin K antagonists in antiphospholipid syndrome: A meta-analysis.
    Pau Cerdà, Cecilia Becattini, Adriana Iriarte, Josefina Cortés-Hernández, Xavier Corbella, Antoni Riera‐Mestre · 2020 · European Journal of Internal Medicine
  72. Management of pregnancy in autoimmune rheumatic diseases: maternal disease course, gestational and neonatal outcomes and use of medications in the prospectiveItalian P-RHEUM.it study
    Laura Andréoli, Maria Chiara Gerardi, Maria Gerosa, Davide Rozza, Francesca Crisafulli, Roberta Erra, Daniele Lini, Laura Trespìdi, Melissa Padovan J J, Francesca Ruffilli et al. · 2024 · RMD Open
  73. Thrombotic Microangiopathy in Pregnancy: Current Understanding and Management Strategies
    Manuel Urra, Shannon Lyons, Corina Gabriela Teodosiu, Richard M. Burwick, Anuja Java · 2024 · Kidney International Reports
  74. Autoantibodies in Systemic Lupus Erythematosus: Diagnostic and Pathogenic Insights
    Eleni Pagkopoulou, Charalampos Loutradis, Maria Papaioannou, Maria Daoudaki, Maria J. Stangou, Theodoros Dimitroulas · 2025 · Journal of Clinical Medicine
  75. Antiphospholipid Antibodies From Women With Pregnancy Morbidity and Vascular Thrombosis Induce Endothelial Mitochondrial Dysfunction, mTOR Activation, and Autophagy
    Carlos M. Rodríguez, Manuela Velásquez, Carolina Rúa, Marta Viana, Vikki M. Abrahams, Ángela Patricia Cadavid, Ángela M. Álvarez · 2021 · Frontiers in Physiology
  76. Managing Antiphospholipid Syndrome in Children and Adolescents: Current and Future Prospects
    Aline Garcia Islabão, Vítor Cavalcanti da Trindade, Lícia Maria Henrique da Mota, DANIELI CASTRO OLIVEIRA DE ANDRADE, Clóvis A. Silva · 2021 · Pediatric Drugs
  77. Circulating immune-complexes of IgG/IgM bound to B2-glycoprotein-I associated with complement consumption and thrombocytopenia in antiphospholipid syndrome
    Laura Naranjo, Ljudmila Stojanovich, Aleksandra Djoković, Laura Andréoli, Anǵela Tincani, Maria Maślińska, Savino Sciascia, Maria Giaele Infantino, Sara Garcinuño, Kinga Kostyra-Grabczak et al. · 2022 · Frontiers in Immunology
  78. Advances in the Research on Anticardiolipin Antibody
    Dan Wang, Wenxin Lv, Shi-Chang Zhang · 2019 · Journal of Immunology Research
  79. Clinical features associated with pregnancy outcomes in women with positive antiphospholipid antibodies and previous adverse pregnancy outcomes: a real-world prospective study
    Xinyi Li, Xiaoli Deng, Hongji Duan, Lin Zeng, Jiansuo Zhou, Chang Liu, Xiaoyue Mona Guo, Xiangyuan Liu · 2020 · Clinical Rheumatology
  80. Vignette-based comparative analysis of ChatGPT and specialist treatment decisions for rheumatic patients: results of the Rheum2Guide study
    Hannah Labinsky, Lea-Kristin Nagler, Martin Krusche, Sebastian Griewing, Peer Malte Aries, Anja Kroiß, Patrick‐Pascal Strunz, Sebastian Kühn, Marc Schmalzing, Michael Gernert et al. · 2024 · Rheumatology International
  81. Understanding and Preventing Placenta-Mediated Pregnancy Complications
    Leslie Skeith, Marc Blondon, Fionnuala Ní Áinle · 2020 · Hämostaseologie
  82. B cells in primary antiphospholipid syndrome: Review and remaining challenges
    Yannick Dieudonné, Aurélien Guffroy, Vincent Poindron, Pauline Soulas-Sprauel, Thierry Martin, Anne‐Sophie Korganow, Vincent Gies · 2021 · Autoimmunity Reviews
  83. On the importance of physicochemical parameters of copper and aminosilane functionalized mesoporous silica for hydroxychloroquine release
    Anna Olejnik, Joanna Gościańska · 2021 · Materials Science and Engineering C
  84. Effects of anti‐beta 2‐glycoprotein 1 antibodies and its association with pregnancy‐related morbidity in antiphospholipid syndrome
    Juan J. Fierro, Manuela Velásquez, Angela P. Cadavid, Karina de Leeuw · 2021 · American Journal of Reproductive Immunology
  85. Which patients are at high risk of recurrent venous thromboembolism (deep vein thrombosis and pulmonary embolism)?
    Fionnuala Ní Áinle, Barry Kevane · 2020 · Hematology
  86. Cutaneous Involvement in Catastrophic Antiphospholipid Syndrome in a Multicenter Cohort of 65 Patients
    Anastasia Dupré, Nathalie Morel, Cécile Yelnik, Philippe Moguelet, Véronique Le Guern, Romain Stammler, Yann Nguyen, Romain Paule, Virginie Dufrost, Félix Ackermann et al. · 2022 · JAMA Dermatology
  87. Telemedicine-Based Management of Oral Anticoagulation Therapy: Systematic Review and Meta-analysis
    Letícia Braga Ferreira, Rodrigo Lanna de Almeida, Alair Arantes, Hebatullah Mohamed Abdulazeem, Ishanka Weerasekara, Leticia Santos Dias Norberto Ferreira, Luana Fonseca de Almeida Messias, Luciana Siuves Ferreira Couto, Maria Auxiliadora Parreiras Martins, Núbia Suelen Antunes et al. · 2023 · Journal of Medical Internet Research
  88. The effects of hydroxychloroquine and its promising use in refractory obstetric antiphospholipid syndrome
    Juan J. Fierro, Manuela Velásquez, Alexandra Ospina, Svenja Henning, Karina de Leeuw, Ángela P. Cadavid J · 2023 · Rheumatology International
  89. Direct oral anticoagulants versus vitamin K antagonists in patients with antiphospholipid syndrome: systematic review and meta-analysis
    Nazariy Koval, Mariana Alves, Rui Plácido · 2021 · RMD Open
  90. Modern management of pregnancy in systemic lupus erythematosus: from prenatal counseling to postpartum support
    Gamba, Anna, Zen, Margherita, Depascale, Roberto, Calligaro, Antonia, Gatto, Mariele, Iaccarino, Luca, Doria, Andrea · 2024 · Journal of Clinical Medicine
  91. Pregnancy in antiphospholipid syndrome: what should a rheumatologist know?
    Laura Andréoli, Francesca Regola, Alessia Caproli, Francesca Crisafulli, Micaela Fredi, Maria Grazia Lazzaroni, Cecilia Nalli, Silvia Piantoni, Sonia Zatti, Franco Franceschini et al. · 2023 · Rheumatology
  92. Hydroxychloroquine: A double‑edged sword (Review)
    Rongxiu Huo, Chengcheng Wei, Yanting Yang, Jinying Lin, Xinxiang Huang · 2025 · Molecular Medicine Reports
  93. Thrombocytopenia in primary antiphospholipid syndrome, a marker of high-risk patients?
    Cécile Yelnik, Yann Nguyen, Véronique Le Guern, Eric HACHULLA, M. Lambert · 2020 · European Journal of Internal Medicine
  94. Arterial Thrombosis in Patients with Antiphospholipid Syndrome: A Review and Meta-Analysis
    Jesús Aibar, Sam Schulman · 2021 · Seminars in Thrombosis and Hemostasis
  95. A glimpse into the future of systemic lupus erythematosus
    Martin Aringer, Marta Eugenia Alarcón-Riquelme, Megan E. B. Clowse, Guillermo J. Pons-Estel, Edward M J Vital, Maria Dall’Era · 2022 · Therapeutic Advances in Musculoskeletal Disease
  96. B-Cells and BAFF in Primary Antiphospholipid Syndrome, Targets for Therapy?
    Lucas L. van den Hoogen, Radjesh J. Bisoendial · 2022 · Journal of Clinical Medicine
  97. The methods for removal of direct oral anticoagulants and heparins to improve the monitoring of hemostasis: a narrative literature review
    Aleksandra Frackiewicz, Bartłomiej Kałaska, Joanna Mikłosz, Andrzej Mogielnicki · 2023 · Thrombosis Journal
  98. Prevalence of Antiphospholipid Antibodies Negativisation in Patients with Antiphospholipid Syndrome: A Long-Term Follow-Up Multicentre Study
    Massimo Radin, Karen Ingrid Schreiber, Savino Sciascia, Dario Roccatello, Irene Cecchi, Maria Angeles Aguirre, María José Cuadrado · 2019 · Thrombosis and Haemostasis
  99. Assessment of the 2023 ACR/EULAR antiphospholipid syndrome classification criteria in a Chinese cohort: Impact on clinical practice
    Yaqing Yang, Haiyue Jiang, Zihan Tang, Haoyu Pan, Honglei Liu, Xiaobing Cheng, Yutong Su, Junna Ye, Qiongyi Hu, Jianfen Meng et al. · 2024 · Journal of Autoimmunity
  100. Recent Advances in Anticoagulant Treatment of Immune Thrombosis: A Focus on Direct Oral Anticoagulants in Heparin-Induced Thrombocytopenia and Anti-Phospholipid Syndrome
    Julie Carré, Georges Jourdi, Nicolas Gendron, Dominique Helley, Pascale Gaussem, Luc Darnige · 2021 · International Journal of Molecular Sciences